New drug duo challenges standard treatment in major lung cancer trial

NCT ID NCT06472076

Ongoing Disease control Sponsor: GlaxoSmithKline Source: ClinicalTrials.gov ↗

Summary

This large, late-stage trial is comparing a new two-drug combination (belrestotug + dostarlimab) against the current standard treatment (pembrolizumab) for people with advanced non-small cell lung cancer who have not had prior treatment. The main goals are to see if the new combination is safe and if it works better to control the cancer. The study is for patients whose cancer has a specific marker (high PD-L1) and cannot be removed by surgery.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

GSK Investigational Site

Ocala, Florida, 34474, United States
GSK Investigational Site

Honolulu, Hawaii, 96819, United States
GSK Investigational Site

Lexington, Kentucky, 40503, United States
GSK Investigational Site

Lexington, Kentucky, 40509, United States
GSK Investigational Site

Ann Arbor, Michigan, 48106, United States
GSK Investigational Site

Omaha, Nebraska, 68114, United States
GSK Investigational Site

Nashville, Tennessee, 37203, United States
GSK Investigational Site

Fort Worth, Texas, 76104, United States
GSK Investigational Site

Olympia, Washington, 98506, United States
GSK Investigational Site

Buenos Aires, 1425, Argentina
GSK Investigational Site

Cipoletti Rio Negro, R8324CVE, Argentina
GSK Investigational Site

Ciudad Autonoma de Buenos Aire, C1426AGE, Argentina
GSK Investigational Site

Ciudad Autonoma de Bueno, C1056ABI, Argentina
GSK Investigational Site

Córdoba, 5000, Argentina
GSK Investigational Site

Florida, 1602, Argentina
GSK Investigational Site

Mendoza, M5500AYB, Argentina
GSK Investigational Site

Rosario, S2002KDT, Argentina
GSK Investigational Site

Rosario, S2002, Argentina
GSK Investigational Site

San Miguel de Tucumán, T4000, Argentina
GSK Investigational Site

Hasselt, 3500, Belgium
GSK Investigational Site

Mont Gaston, 5530, Belgium
GSK Investigational Site

Barretos, 14784-400, Brazil
GSK Investigational Site

Belém, 66.073-005, Brazil
GSK Investigational Site

CuritibaPR, 80810-050, Brazil
GSK Investigational Site

Florianópolis, 88034-000, Brazil
GSK Investigational Site

Fortaleza, 60336-232, Brazil
GSK Investigational Site

Londrina, 86015-520, Brazil
GSK Investigational Site

Porto VelhoRondOnia, 76.834-899, Brazil
GSK Investigational Site

Salvador, 40414-120, Brazil
GSK Investigational Site

SAo JosE Do Rio PretoSP, 15090-000, Brazil
GSK Investigational Site

São Paulo, 04312903, Brazil
GSK Investigational Site

Vitória, 29043-260, Brazil
GSK Investigational Site

Haskovo, 6300, Bulgaria
GSK Investigational Site

Plovdiv, 4004, Bulgaria
GSK Investigational Site

Halifax, Nova Scotia, B3H 1V7, Canada
GSK Investigational Site

Chengdu, 610000, China
GSK Investigational Site

Hangzhou, 310006, China
GSK Investigational Site

Hangzhou, China
GSK Investigational Site

Hefei, 230001, China
GSK Investigational Site

Nanjing, 210006, China
GSK Investigational Site

Shanghai, 200030, China
GSK Investigational Site

Kuopio, 70210, Finland
GSK Investigational Site

Turku, 20520, Finland
GSK Investigational Site

Angers, 49000, France
GSK Investigational Site

Boulogne-Billancourt, 92100, France
GSK Investigational Site

Limoges, 87042, France
GSK Investigational Site

Lorient, 56100, France
GSK Investigational Site

Pessac, 33064, France
GSK Investigational Site

Rennes, 35033, France
GSK Investigational Site

Hamburg, 20251, Germany
GSK Investigational Site

Shatin, Hong Kong
GSK Investigational Site

Gokul Shirgoan, Kolhapur, 416234, India
GSK Investigational Site

Ahmedabad-380016, 380 016, India
GSK Investigational Site

Apex Wellness Hospital, 422005, India
GSK Investigational Site

Bangalore, 560066, India
GSK Investigational Site

Bangalore, 560085, India
GSK Investigational Site

Belagavi, 590010, India
GSK Investigational Site

Bhubaneshwar, 751007, India
GSK Investigational Site

Bhubaneswar, 751019, India
GSK Investigational Site

Gūrgaon, 122001, India
GSK Investigational Site

Kolkata, 700020, India
GSK Investigational Site

New Delhi, 110075, India
GSK Investigational Site

Aichi, 466-8560, Japan
GSK Investigational Site

Chiba, 273-8588, Japan
GSK Investigational Site

Ehime, 790-0024, Japan
GSK Investigational Site

Ehime, 791-0280, Japan
GSK Investigational Site

Fukuoka, 812-8582, Japan
GSK Investigational Site

Fukuoka, 814-0180, Japan
GSK Investigational Site

Gifu, 503-8502, Japan
GSK Investigational Site

Gunma, 377-0280, Japan
GSK Investigational Site

Hiroshima, 737-0023, Japan
GSK Investigational Site

Hokkaido, 062-0931, Japan
GSK Investigational Site

Hyōgo, 665-0827, Japan
GSK Investigational Site

Hyōgo, 670-8520, Japan
GSK Investigational Site

Kanagawa, 236-0051, Japan
GSK Investigational Site

Kyoto, 612-8555, Japan
GSK Investigational Site

Mie, 515-8544, Japan
GSK Investigational Site

Miyagi, 981-0914, Japan
GSK Investigational Site

Miyagi, 981-1293, Japan
GSK Investigational Site

Nagasaki, 852-8501, Japan
GSK Investigational Site

Niigata, 951-8566, Japan
GSK Investigational Site

Okayama, 710-8602, Japan
GSK Investigational Site

Osaka, 591-8555, Japan
GSK Investigational Site

Osaka, 596-8501, Japan
GSK Investigational Site

Tochigi, 329-0498, Japan
GSK Investigational Site

Tokyo, 104-0045, Japan
GSK Investigational Site

Tokyo, 113-8603, Japan
GSK Investigational Site

Tokyo, 162-8655, Japan
GSK Investigational Site

Tottori, 683-8504, Japan
GSK Investigational Site

Wakayama, 641-8510, Japan
GSK Investigational Site

Guadajalara, 44280, Mexico
GSK Investigational Site

La Paz BCS, 23040, Mexico
GSK Investigational Site

Mexico City, 06700, Mexico
GSK Investigational Site

San Luis Potosí City, 78209, Mexico
GSK Investigational Site

Alkmaar, 1815 JD, Netherlands
GSK Investigational Site

Enschede, 7512 KZ, Netherlands
GSK Investigational Site

Panama City, Panama
GSK Investigational Site

Punta Pacifica Panama City Panama, Panama
GSK Investigational Site

Daegu, 41404, South Korea
GSK Investigational Site

Incheon, 21565, South Korea
GSK Investigational Site

Seoul, 02841, South Korea
GSK Investigational Site

Seoul, 03312, South Korea
GSK Investigational Site

Seoul, 05505, South Korea
GSK Investigational Site

Seoul, 08308, South Korea
GSK Investigational Site

Seoul, 120-752, South Korea
GSK Investigational Site

A Coruña, 15006, Spain
GSK Investigational Site

Aravaca, 28013, Spain
GSK Investigational Site

BaracaldoVizcaya, 48903, Spain
GSK Investigational Site

Barcelona, 08003, Spain
GSK Investigational Site

Barcelona, 08023, Spain
GSK Investigational Site

Barcelona, 08025, Spain
GSK Investigational Site

Barcelona, 08035, Spain
GSK Investigational Site

Cartagena Murcia, 30202, Spain
GSK Investigational Site

Córdoba, 14004, Spain
GSK Investigational Site

Jaén, 23007, Spain
GSK Investigational Site

Las Palmas de Gran Canar, 35016, Spain
GSK Investigational Site

Madrid, 28007, Spain
GSK Investigational Site

Madrid, 28010, Spain
GSK Investigational Site

Madrid, 28033, Spain
GSK Investigational Site

Madrid, 28222, Spain
GSK Investigational Site

Málaga, 29016, Spain
GSK Investigational Site

Oviedo, 33006, Spain
GSK Investigational Site

Pamplona, 31008, Spain
GSK Investigational Site

Salamanca, 37007, Spain
GSK Investigational Site

Santander, 39008, Spain
GSK Investigational Site

Seville, 41014, Spain
GSK Investigational Site

Valladolid, 47003, Spain
GSK Investigational Site

Gävle, SE-801 87, Sweden
GSK Investigational Site

Kaohsiung City, 807, Taiwan
GSK Investigational Site

Taipei, 23561, Taiwan
GSK Investigational Site

Adana, 1120, Turkey (Türkiye)
GSK Investigational Site

Ankara, 06560, Turkey (Türkiye)
GSK Investigational Site

Ankara, 06800, Turkey (Türkiye)
GSK Investigational Site

Istanbul, 34722, Turkey (Türkiye)

Conditions

Explore the condition pages connected to this study.

LUNG CANCER (NON-SMALL CELL)